Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Florida › Tampa
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Tampa, FL keessatti
Qorannoo 29 Leukemia Myeloidii Hamaa f Tampa fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center-International Plaza, Tampa
- Moffitt Cancer Center - McKinley Campus, Tampa
- Moffitt Cancer Center, Tampa
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 2/3
- Moffitt Cancer Center /ID# 279192, Tampa
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 3
- Moffit Cancer center, Tampa
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Namoota walitti qabaa jiraSadarkaa 3
- Tampa General Hospital, Tampa
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
A Study of BGB-11417 in Participants With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Tampa General Hospital, Tampa
A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 1/2
- Moffitt Cancer Center and Research Institute Hospital, Tampa
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1/2
- Moffitt Cancer Center, Tampa
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 3
- Saint Joseph's Hospital - Tampa, Tampa
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Namoota walitti qabaa jiraSadarkaa 3
- Moffitt Cancer Center & Research Institute, Tampa
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- H Lee Moffitt Cancer Center & Research Institute, Tampa
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Namoota walitti qabaa jiraSadarkaa 3
- Moffitt Cancer Center, Tampa
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
BCL2i CLAG-M in R/R Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Namoota walitti qabaa jiraSadarkaa 1/2
- Moffitt Cancer Center, Tampa
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD
Namoota walitti qabaa jiraSadarkaa 2
- Moffitt Cancer Center, Tampa
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt, Tampa
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Safety of MT-401-OTS in Patients With Relapsed AML or MDS
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Moffitt Cancer Center, Tampa
Study of REM-422 in Patients With AML or Higher Risk MDS
Namoota walitti qabaa jiraSadarkaa 1
- Moffitt Cancer Center, Tampa
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Seattle, WAQorannoo 41
- Baldwin Park, CAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 31
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
- Washington, DCQorannoo 24
Qorannoo biroo Tampa keessatti
- Kansara Qara'a Non-Small CellQorannoo 51
- Saree OljooQorannoo 43
- Saree (Gosoota Hunda)Qorannoo 39
- Kansarii ColorectalQorannoo 34
- Kansara MetastatikiiQorannoo 29
- Dhibee QaraQorannoo 29
- Kansarii PancreasQorannoo 26
- Kansarii OvariiQorannoo 21
- MelanomaQorannoo 19
- Myelodysplastic SyndromesQorannoo 19
- Kansarii ProstateQorannoo 18
- Cufama OnneeQorannoo 18
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.